AAAAAA

   
Results: 1-23 |
Results: 23
Ototoxicity may be associated with protease inhibitor therapy - Reply
Authors: Simdon, J Watters, D Bartlett, S Connick, E
Citation: J. Simdon et al., Ototoxicity may be associated with protease inhibitor therapy - Reply, CLIN INF D, 33(12), 2001, pp. 2101-2102
Ototoxicity associated with use of nucleoside analog reverse transcriptaseinhibitors: A report of 3 possible cases and review of the literature
Authors: Simdon, J Watters, D Bartlett, S Connick, E
Citation: J. Simdon et al., Ototoxicity associated with use of nucleoside analog reverse transcriptaseinhibitors: A report of 3 possible cases and review of the literature, CLIN INF D, 32(11), 2001, pp. 1623-1627
Multiple CD4(+) cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highlyactive antiretroviral therapy
Authors: Wu, HL Connick, E Kuritzkes, DR Landay, A Spritzler, J Zhang, B Spear, GT Kessler, H Lederman, MM
Citation: Hl. Wu et al., Multiple CD4(+) cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highlyactive antiretroviral therapy, AIDS RES H, 17(13), 2001, pp. 1231-1240
Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion
Authors: Connick, E Schlichtemeier, RL Purner, MB Schneider, KM Anderson, DM MaWhinney, S Campbell, TB Kuritzkes, DR Douglas, JM Judson, FN Schooley, RT
Citation: E. Connick et al., Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion, J INFEC DIS, 184(11), 2001, pp. 1465-1469
Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection
Authors: Schacker, T Little, S Connick, E Gebhard, K Zhang, ZQ Krieger, J Pryor, J Havlir, D Wong, JK Schooley, RT Richman, D Corey, L Haase, AT
Citation: T. Schacker et al., Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection, J INFEC DIS, 183(4), 2001, pp. 555-562
A potential role for interleukin-7 in T-cell homeostasis
Authors: Fry, TJ Connick, E Falloon, J Lederman, MM Liewehr, DJ Spritzler, J Steinberg, SM Wood, LV Yarchoan, R Zuckerman, J Landay, A Mackall, CL
Citation: Tj. Fry et al., A potential role for interleukin-7 in T-cell homeostasis, BLOOD, 97(10), 2001, pp. 2983-2990
Shipment impairs lymphocyte proliferative responses to microbial antigens
Authors: Betensky, RA Connick, E Devers, J Landay, AL Nokta, M Plaeger, S Rosenblatt, H Schmitz, JL Valentine, F Wara, D Weinberg, A Lederman, HM
Citation: Ra. Betensky et al., Shipment impairs lymphocyte proliferative responses to microbial antigens, CL DIAG LAB, 7(5), 2000, pp. 759-763
Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen
Authors: Valdez, H Smith, KY Landay, A Connick, E Kuritzkes, DR Kessler, H Fox, L Spritzler, J Roe, J Lederman, MB Lederman, HM Evans, TG Heath-Chiozzi, M Lederman, MM
Citation: H. Valdez et al., Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen, AIDS, 14(1), 2000, pp. 11-21
Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) frompatients with primary HIV infection to nonnucleoside reverse transcriptaseinhibitors is associated with variation at novel amino acid sites
Authors: Brown, AJL Precious, HM Whitcomb, JM Wong, JK Quigg, M Huang, W Daar, ES D'Aquila, RT Keiser, PH Connick, E Hellmann, NS Petropoulos, CJ Richman, DD Little, SJ
Citation: Ajl. Brown et al., Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) frompatients with primary HIV infection to nonnucleoside reverse transcriptaseinhibitors is associated with variation at novel amino acid sites, J VIROLOGY, 74(22), 2000, pp. 10269-10273
Phase 1 trial of a single dose of recombinant human interleukin-12, in human immunodeficiency virus-infected patients with 100-500 CD4 cells/mu L
Authors: Jacobson, MA Hardy, D Connick, E Watson, J DeBruin, M
Citation: Ma. Jacobson et al., Phase 1 trial of a single dose of recombinant human interleukin-12, in human immunodeficiency virus-infected patients with 100-500 CD4 cells/mu L, J INFEC DIS, 182(4), 2000, pp. 1070-1076
Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: Genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS Clinical Trials Group protocol 315
Authors: Kuritzkes, DR Sevin, A Young, B Bakhtiari, M Wu, HL St Clair, M Connick, E Landay, A Spritzler, J Kessler, H Lederman, MM
Citation: Dr. Kuritzkes et al., Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: Genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS Clinical Trials Group protocol 315, J INFEC DIS, 181(2), 2000, pp. 491-497
Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy
Authors: Smith, KY Valdez, H Landay, A Spritzler, J Kessler, HA Connick, E Kuritzkes, D Gross, B Francis, I McCune, JM Lederman, MM
Citation: Ky. Smith et al., Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy, J INFEC DIS, 181(1), 2000, pp. 141-147
Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: Implications for timingof antiretroviral therapy
Authors: Schacker, T Little, S Connick, E Gebhard-Mitchell, K Zhang, ZQ Krieger, J Pryor, J Havlir, D Wong, JK Richman, D Corey, L Haase, AT
Citation: T. Schacker et al., Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: Implications for timingof antiretroviral therapy, J INFEC DIS, 181(1), 2000, pp. 354-357
Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response
Authors: Connick, E Lederman, MM Kotzin, BL Spritzler, J Kuritzkes, DR St Clair, M Sevin, AD Fox, L Chiozzi, MH Leonard, JM Rousseau, F Roe, JD Martinez, A Kessler, H Landay, A
Citation: E. Connick et al., Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response, J INFEC DIS, 181(1), 2000, pp. 358-363
Prolonged survival and tissue trafficking following adoptive transfer of CD4 zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects
Authors: Mitsuyasu, RT Anton, PA Deeks, SG Scadden, DT Connick, E Downs, MT Bakker, A Roberts, MR June, CH Jalali, S Lin, AA Pennathur-Das, R Hege, KM
Citation: Rt. Mitsuyasu et al., Prolonged survival and tissue trafficking following adoptive transfer of CD4 zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects, BLOOD, 96(3), 2000, pp. 785-793
Efficacy and safety of delavirdine mesylate with zidovudine and didanosinecompared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm(3) (ACTG 261)
Authors: Friedland, GH Pollard, R Griffith, B Hughes, M Morse, G Bassett, R Freimuth, W Demeter, L Connick, E Nevin, T Hirsch, M Fischl, M
Citation: Gh. Friedland et al., Efficacy and safety of delavirdine mesylate with zidovudine and didanosinecompared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm(3) (ACTG 261), J ACQ IMM D, 21(4), 1999, pp. 281-292
Increases in T cell telomere length in HIV infection after antiretroviral combination therapy for HIV-1 infection implicate distinct population dynamics in CD4(+) and CD8(+) T cells
Authors: Kaushal, S Landay, AL Lederman, MM Connick, E Spritzler, J Kuritzkes, DR Kessler, H Levine, BL St Louis, DC June, CH
Citation: S. Kaushal et al., Increases in T cell telomere length in HIV infection after antiretroviral combination therapy for HIV-1 infection implicate distinct population dynamics in CD4(+) and CD8(+) T cells, CLIN IMMUNO, 92(1), 1999, pp. 14-24
Alteration of complement protein levels after antiretroviral therapy in HIV-infected persons
Authors: Spear, GT Olinger, G Sullivan, BL Landay, AL Kessler, H Connick, E Kuritzkes, D St Clair, M Spritzler, J Wu, H Lederman, MM
Citation: Gt. Spear et al., Alteration of complement protein levels after antiretroviral therapy in HIV-infected persons, AIDS RES H, 15(18), 1999, pp. 1713-1715
Small differences in CD4+ T-cell production may go unnoticed
Authors: Shapiro, HM Lederman, M Connick, E Kessler, H Kuritzkes, DR Landay, AL
Citation: Hm. Shapiro et al., Small differences in CD4+ T-cell production may go unnoticed, AIDS, 13(2), 1999, pp. 290-291
Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection
Authors: Andersson, J Behbahani, H Lieberman, J Connick, E Landay, A Patterson, B Sonnerborg, A Lore, K Uccini, S Fehniger, TE
Citation: J. Andersson et al., Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection, AIDS, 13(11), 1999, pp. 1295-1303
HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication
Authors: Patki, AH Purvis, SF Valdez, H Spritzler, J Connick, E Kuritzkes, DR Kessler, H Fox, L St Claire, M Landay, A Lederman, MM
Citation: Ah. Patki et al., HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication, AIDS, 13(10), 1999, pp. 1177-1185
Reduced antiretroviral drug susceptibility among patients with primary HIVinfection
Authors: Little, SJ Daar, ES D'Aquila, RT Keiser, PH Connick, E Whitcomb, JM Hellmann, NS Petropoulos, CJ Sutton, L Pitt, JA Rosenberg, ES Koup, RA Walker, BD Richman, DD
Citation: Sj. Little et al., Reduced antiretroviral drug susceptibility among patients with primary HIVinfection, J AM MED A, 282(12), 1999, pp. 1142-1149
Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: Relationships to host factors, cellular restoration, and virologic end points
Authors: Wu, HL Kuritzkes, DR McClernon, DR Kessler, H Connick, E Landay, A Spear, G Heath-Chiozzi, M Rousseau, F Fox, L Spritzler, J Leonard, JM Lederman, MM
Citation: Hl. Wu et al., Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: Relationships to host factors, cellular restoration, and virologic end points, J INFEC DIS, 179(4), 1999, pp. 799-807
Risultati: 1-23 |